$OCGN 4 SEC Filings

Filed On	Filing
13 Oct 2026	Form 4: Musunuri Shankar, Director Sold 525,991 shares ($500K)
11 Sep 2026	Form 4: Musunuri Shankar, Director Sold 525,991 shares ($589K)
17 Jun 2026	Form 4: Johnson-Greene Treerita Essalima, Chief Financial Officer Bought 21,000 shares ($25.8K)
15 Jun 2026	Form 4: Kompella Uday, Director Granted 170,100 Stock Option (Right to Buy)
15 Jun 2026	Form 4: Chandrasekhar Satishchandran, Director Granted 170,100 Stock Option (Right to Buy)
15 Jun 2026	Form 4: Castillo Kirsten, Director Granted 170,100 Stock Option (Right to Buy)
15 Jun 2026	Form 4: Zhang Junge, Director Granted 170,100 Stock Option (Right to Buy)
15 Jun 2026	Form 4: Coleman Blaise, Director Granted 170,100 Stock Option (Right to Buy)
02 Apr 2026	Form 4: Zhang Junge, Director Received 194,134 shares by exercise or conversion ($154K)
06 Jan 2026	Form 4: Musunuri Shankar, Director Received 3,123,201 shares as a grant or award · Granted 3,123,201 Option (Right to Buy)
06 Jan 2026	Form 4: Ramachandran Ramesh, Chief Accounting Officer Received 207,300 shares as a grant or award · Granted 310,950 Option (Right to Buy)
09 Jun 2025	Form 4: Chandrasekhar Satishchandran, Director Granted 151,316 Option (Right to Buy)
09 Jun 2025	Form 4: Coleman Blaise, Director Granted 151,316 Option (Right to Buy)
09 Jun 2025	Form 4: Castillo Kirsten, Director Granted 151,316 Option (Right to Buy)
09 Jun 2025	Form 4: Kompella Uday, Director Granted 151,316 Option (Right to Buy)
09 Jun 2025	Form 4: Zhang Junge, Director Granted 151,316 Option (Right to Buy)
06 Jan 2025	Form 4: Ramachandran Ramesh, Chief Accounting Officer Granted 350,146 Option (Right to Buy)
06 Jan 2025	Form 4: Upadhyay Arun, See Remarks Granted 730,994 Option (Right to Buy) · Gave up 41,633 shares to cover exercise price or tax ($37.2K)
06 Jan 2025	Form 4: Musunuri Shankar, Director Granted 1,827,485 Option (Right to Buy) · Gave up 177,146 shares to cover exercise price or tax ($158K)
06 Jan 2025	Form 4: Qamar Huma, Chief Medical Officer Granted 1,145,468 Option (Right to Buy)

Comments